WeightWatchers (WW) Shares Skyrocket, What You Need To Know [Yahoo! Finance]
Novo Nordisk A/S (NVO)
Last novo nordisk a/s earnings: 2/5 01:31 am
Check Earnings Report
US:NYSE Investor Relations:
novonordisk.com/investors.html
Company Research
Source: Yahoo! Finance
Food and Drug Administration (FDA) approved an oral version of the popular weight-loss drug Wegovy. This development was viewed as a major positive for WeightWatchers, which recently launched its own program that integrated GLP-1 medications. The approval of an oral version of Wegovy, made by Novo Nordisk, made this class of treatment more accessible to consumers. The timing of the news was also significant, as it arrived just before January, which is WeightWatchers' most important period for acquiring new customers. The approval provided a positive signal for the company's strategy of combining its services with medical weight-loss treatments. Is now the time to buy WeightWatchers? Access our full analysis report here WeightWatchers's shares are extremely volatile and have had 37 moves greater than 5% over the last year. But moves this big are rare even for WeightWatchers and indicate this news significantly impacted the market's perception of the business. The previous big m
Show less
Read more
Impact Snapshot
Event Time:
NVO
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
NVO alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
NVO alerts
High impacting Novo Nordisk A/S news events
Weekly update
A roundup of the hottest topics
NVO
News
- Stock Market Today, Dec. 23: U.S. Stocks Hold Near Records on Narrow Tech-Led Gains [Yahoo! Finance]Yahoo! Finance
- Novo Nordisk says FDA approved Wegovy pill to reduce body weight [Yahoo! Finance]Yahoo! Finance
- Launch of Wegovy pill is core to Novo Nordisk's growth, says Guggenheim's Seamus Fernandez [CNBC]CNBC
- Why Novo Nordisk Stock Popped Today [Yahoo! Finance]Yahoo! Finance
- Stock Market Today, Dec. 23: Novo Nordisk Surges After FDA Approves Oral Wegovy Weight Loss Pill [Yahoo! Finance]Yahoo! Finance
NVO
Earnings
- 11/6/25 - Beat
NVO
Sec Filings
- 12/23/25 - Form 6-K
- 11/25/25 - Form 6-K
- 11/24/25 - Form 6-K
- NVO's page on the SEC website